Editorial Standards • New AI Health

Why This Page Exists

New AI Health is an independent editorial review of emerging companies, technologies, publications, and public signals across the developing Health AI field.

The purpose of the site is to identify meaningful category movement, describe observable product and company boundaries, and make the field easier to understand. It is not a paid directory, procurement guide, medical advice resource, certification body, or investment research service.

Health AI is still forming. Companies may operate across clinical workflows, diagnostic systems, evidence infrastructure, healthcare operations, patient support, governance, data systems, robotics, and health-specific applications. These areas should not be evaluated as though they carry identical purposes, evidence requirements, or responsibilities.

This page explains how New AI Health selects, organizes, describes, and updates the subjects it reviews.

Publisher and Maintenance

New AI Health is maintained as a public editorial research and company discovery publication. Profiles and publications are based on public-facing information, observed product surfaces, public updates, primary materials where available, and editorial review.

The site is intended to help readers understand the emerging Health AI field by organizing companies and topics into clear discovery surfaces, describing observable public signals, and identifying where product and responsibility boundaries appear to matter.

Pages may be updated as companies change their products, public positioning, partnerships, deployment posture, category fit, or available public documentation.

How New AI Health Organizes the Field

Health AI is not treated as one uniform software category. New AI Health uses several editorial frameworks to help readers understand different parts of the field.

Current discovery surfaces include Companies, Medical AI, Diagnostic AI, Evidence AI, Health Systems, Medical Robotics, Policy and Regulation, General AI, Men’s Health, and Women’s Health.

Some publications may be presented as Signals when they are intended to identify early category movement, emerging evidence, policy change, or a developing sector pattern. These remain part of the New AI Health publication system rather than a separate ranking, certification, or formal classification framework.

These frameworks are navigational and editorial. They are not formal industry standards, regulatory classifications, or permanent taxonomies. Categories may evolve as products, evidence, regulation, and public understanding change.

The purpose of classification is to clarify what a system appears to do, where it operates, and what kinds of evidence, governance, or human oversight may be relevant.

What We Look For

New AI Health looks for companies, systems, and public developments that show signs of meaningful and responsible category creation.

We look for one or more of the following traits:

A clear problem in healthcare or health-adjacent operations.
A focused product or system rather than vague AI positioning.
A responsible stance toward clinical decision-making.
Evidence of workflow, research, infrastructure, or patient relevance.
A useful relationship with existing healthcare systems.
Clear separation between support, automation, infrastructure, evidence, and medical judgment.
Careful handling of sensitive health, patient, operational, or financial data.
Potential to improve access, efficiency, safety, understanding, or system reliability.

We are especially interested in companies and systems that understand their boundaries.

Responsible Health AI is not defined only by what a system can do. It is also shaped by what its builders refuse to overclaim.

What Responsible Direction Looks Like

When New AI Health highlights a company or development, it does not mean that the subject has been certified, clinically validated, or judged to be free of risk. It means the public direction appears relevant enough to merit careful attention.

For Medical AI and Diagnostic AI, responsible direction may include clinician oversight, evidence quality, auditability, reproducible output, workflow fit, and carefully stated clinical boundaries.

For Evidence AI, governance, and infrastructure systems, it may include source provenance, evaluation quality, model oversight, compliance support, deployment discipline, and clear separation between infrastructure and clinical claims.

For Operational AI and Health Systems, it may include solving meaningful administrative or coordination problems without assuming unsupported clinical authority.

For patient-facing or health-specific systems, it may include clear purpose, understandable limitations, privacy-respecting design, appropriate escalation, and careful separation between informational support and medical judgment.

The common thread is responsible deployment within the complexity of health systems and the vulnerability of the people who depend on them.

Selection and Source Practices

Subjects are selected through editorial judgment based on public-facing information, observable relevance to Health AI, category significance, and the clarity of the available public record.

Sources may include company websites, product pages, regulatory or government materials, technical publications, public announcements, official profiles, LinkedIn pages, Crunchbase listings, visible product surfaces, and other publicly accessible materials.

The site does not claim access to private customer contracts, confidential financial data, non-public clinical validation materials, internal roadmaps, or proprietary technical documentation unless that information has been made public by an authorized source.

When public information is incomplete, New AI Health may identify what remains unclear rather than filling the gap with unsupported claims.

Inclusion is not paid. The site does not operate a quantitative company scoring model or certify comparative quality. Profiles and publications may be grouped or ordered editorially to help readers navigate the field, but that ordering should not be interpreted as an objective performance ranking.

The review is intentionally selective and may include early companies or emerging categories when they represent a meaningful pattern worth observing.

Editorial correspondence, source clarification, and relevant public materials can be sent to editorial@newaihealth.com . Sending material does not guarantee coverage, attribution, publication, confidentiality, or a response.

Editorial Independence

Company inclusion, category placement, and editorial description are not paid placement.

New AI Health may describe a company or development positively when its public positioning, product direction, evidence posture, or category fit appears meaningful. Those descriptions are editorial judgments, not guarantees of quality, safety, adoption, performance, regulatory status, or commercial success.

No company has paid for inclusion, placement, ordering, or favorable description.

Corrections

Health AI moves quickly, and public information can change. If a page contains outdated, incomplete, or incorrect public information, New AI Health may revise it after review.

Corrections should be grounded in verifiable public sources, such as official company materials, regulatory or government records, technical publications, public announcements, product pages, or other publicly accessible primary information.

Updates may include changes to descriptions, category placement, product summaries, public references, source-boundary language, or statements about what remains uncertain.

Correction and update requests can be sent to corrections@newaihealth.com . Requests should identify the affected page, the statement being questioned, and a verifiable public source supporting the proposed correction.

Medical Boundary

New AI Health is an editorial publication. It does not provide medical advice, diagnosis, treatment recommendations, clinical decision support, or patient-specific guidance.

Pages may discuss clinical workflows, medical technologies, diagnostic systems, healthcare operations, patient-support products, health data systems, robotics, evidence, or governance infrastructure. That discussion is informational and should not be interpreted as clinical validation or medical recommendation.

People with health concerns should speak with a qualified healthcare professional.

What This Review Is Not

New AI Health does not recommend treatments, diagnose conditions, advise patients on care decisions, or independently determine whether a product is clinically safe or effective.

It is not an investment research service, procurement recommendation service, paid company directory, regulatory determination, certification program, or product endorsement platform.

Editorial phrases expressing interest or identifying a meaningful direction reflect judgment about public positioning, category fit, evidence posture, or responsible boundaries. They do not establish a partnership, guarantee, certification, or recommendation.

How Profiles May Change

Health AI is moving quickly. Companies may change products, positioning, partnerships, deployment posture, regulatory context, public evidence, or market focus over time.

A company that begins as an operational automation platform may expand into clinical workflows. A clinical documentation company may broaden into care coordination. A data infrastructure company may develop evaluation products. A governance company may become part of a wider deployment layer. A robotics company may add increasingly sophisticated intelligence and evidence systems.

New AI Health may update descriptions, categories, references, or boundaries as the public record changes. The purpose is to map the field as clearly as possible while acknowledging that the field itself is still forming.

Health AI is early. That is why careful public review matters.

Readers evaluating company boundaries, governance posture, responsible deployment, or clinical safety language can review Safe Health AI.

New AI Health also maintains a Health AI Definitions library to clarify terminology used across company profiles, publications, category pages, and explanatory materials.